<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202502</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[Study on cerebral perfusion patterns in premature infants based on multi-delayed arterial spin labeling imaging]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.001</link>
<description><![CDATA[<b>Objective</b>To explore the changes of cerebral perfusion in premature infants with postmenstrual age (PMA) and the differences in cerebral perfusion between premature infants and normal full-term infants at term equivalent age (TEA) based on multidelay arterial spin labeling (MDASL). <b>Materials and Methods</b>Prospective data collection included 36 premature infants (gestational age &lt; 37 weeks) and 18 normal full-term infants (gestational age ≥ 37 weeks), of which 18 premature infants with TEA were matched with 14 normal full-term infants in terms of PMA. All subjects underwent conventional MRI and MDASL scanning at 3.0 T GE premier. MDASL generated cerebral blood flow (CBF) images from 7 different postlabeling delays (PLD) through 8 acquisitions. The original images were processed by functool software to obtain arterial transit times (ATT) and transit time–corrected cerebral blood flow (tCBF) images. Linear regression was used to analyze the trend of tCBF changes with PMA in premature infants and normal full-term infants, and independent sample <i>t</i>-test was used to analyze the differences in tCBF and ATT between premature infants and full-term infants with TEA. <b>Results</b>The tCBF of all regions (except the pons) of normal full-term and premature infants increased with the increase of PMA (<i>P</i> &lt; 0.05), among which the tCBF of the cerebellar hemisphere changed the most. The change of the cerebellar hemisphere in normal full-term infants (b = 0.829, <i>P </i>&lt; 0.05) was greater than that in premature infants (b = 0.518, <i>P</i> &lt; 0.05). Compared with normal full-term infants, the tCBF of premature infants with TEA was significantly higher in frontal white matter, temporal white matter, occipital white matter, frontal cortex, occipital cortex, lenticular nucleus, caudate nucleus, thalamus, hippocampus, cerebellar hemisphere and pons (<i>P</i> &lt; 0.05). ATT in frontal cortex, thalamus and hippocampus of normal full-term infants was longer than that of premature TEA infants (<i>P</i> &lt; 0.05). <b>Conclusions</b>MDASL can more accurately show the regional differences in cerebral perfusion between premature infants and normal full-term infants and the spatiotemporal trajectory of early brain development. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[3D-pCASL in the developmental brain abnormalities of preterm infants born to hypertensive mothers during pregnancy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.002</link>
<description><![CDATA[<b>Objective</b>To quantitatively assess the cerebral blood flow (CBF) values of preterm infants delivered by hypertensive pregnant women during pregnancy using three-dimensional pseudo-continuous arterial spin labeling (3D-pCASL) imaging, and to investigate the potential association between CBF and inflammatory factor levels and Neonatal Behavioral Neurological Assessment (NBNA) scores in preterm infants. <b>Materials and Methods</b>The present study prospectively analyzed 80 preterm infants attending our hospital from July 2023 to June 2024, who were divided into a case group (40 cases) and a control group (40 cases) based on whether their mothers suffered from gestational hypertension or not. Conventional MRI and 3D-pCASL sequence scans were performed in both groups, and the CBF values of each brain region were compared between the two groups. The correlation between the CBF values and inflammatory factors and NBNA scores was analyzed. <b>Results</b>CBF values and inflammatory factor levels in several brain regions of preterm infants born to hypertensive mothers during pregnancy were significantly higher than those of the control group (<i>P</i> &lt; 0.05), whereas NBNA scores were lower than those of the control group (<i>P</i> &lt; 0.05). CBF values in the left frontal lobe, right temporal lobe, left parietal lobe, bilateral basal ganglia regions and thalamus showed some positive correlation with calcitoninogen (<i> r</i> = 0.399, 0.469, 0.482, 0.535, 0.606, 0.692, 0.689, <i>P</i> &lt; 0.05), and CBF values in the bilateral basal ganglia regions and thalamus showed a negative correlation with NBNA scores (<i>r</i> = -0.395, -0.429, -0.414, -0.438, <i>P</i> &lt; 0.05). <b>Conclusions</b>The 3D-pCASL technique can non-invasively assess the CBF values of preterm infants with gestational hypertension in mothers, and elevated CBF values may be associated with poor prognosis of preterm infants with gestational hypertension in mothers, which will help in early diagnosis of brain dysplasia in their preterm infants and interventional treatment. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[MRI deep learning study to predict progression-free survival in brain glioma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.003</link>
<description><![CDATA[<b>Objective</b>To develop and validate a deep learning (DL) model for predicting progression-free survival (PFS) in patients with glioma based on T2WI. <b>Materials and Methods</b>MRI and clinical data from 345 patients diagnosed with glioma across three centers were collected. Nine DL models were established to predict PFS, and their performance was validated using an external test set. The best model was determined by the C-index, and the performances of these models were compared. Patients were stratified into high-risk and low-risk groups based on risk score cutoff values calculated from the training set, and differences in PFS between these groups were assessed. <b>Results</b>The training and test sets consisted of 249 and 96 patients, respectively. Compared with other DL models, the Wide ResNet50-2 DL model performed best, achieving C-indexes of 0.694 and 0.714 in the training and test sets, respectively. A combined model incorporating both clinical and DL features showed the highest performance, with C-indexes of 0.724 and 0.795 in the training and external test sets, respectively. <b>Conclusions</b>A DL model based on preoperative MRI can predict PFS in patients with glioma and may serve as a preoperative risk stratification tool. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A multicenter study of 2.5D convolutional neural networks based on multi-sequence MRI in distinguishing meningioma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.004</link>
<description><![CDATA[<b>Objective</b>To explore the value of 2.5D convolutional neural networks (CNN) based on T2WI, DWI, and enhanced T1WI sequences in distinguishing meningiomas from other similar-appearing tumors. <b>Materials and Methods</b>A total of 674 cases with histopathologically confirmed meningiomas and non-meningiomas with similar imaging features were retrospectively collected from three hospitals (A, B, and C). Among them, 414 cases from hospital A (meningiomas, <i>n</i> = 178; non-meningiomas, <i>n</i> = 236) were used as the training set, 95 cases from hospital B (meningiomas, <i>n</i> = 41; non-meningiomas, <i>n</i> = 54) were used as the test set, and 165 cases from hospital C (meningiomas, <i>n</i> = 78; non-meningiomas: <i>n</i> = 87) were used as the validation set. All cases were classified into five categories: solitary fibrous tumor/ hemangiopericytoma (Class_0), meningioma (Class_1), lymphoma (Class_2), metastatic tumor (Class_3), and cartilage-derived and other similar-appearing tumors (Class_4). A Gradient Boosted Decision Trees (GBDT) model was constructed based on MRI features, and three types of 2.5D CNN, namely ResNet50, DenseNet169, and ResNext50_32x4d, were developed using the input MRI images. After a comprehensive comparison of the performance of these models, the optimal model was selected. Six radiologists with varying levels of experience (two at each level of junior, intermediate, and senior) independently diagnosed cases in the validation set to assess the consistency of the optimal model<sup><sup>,</sup></sup>s diagnostic outcomes with those of radiologists with different levels of experience. <b>Results</b>Among the four multi-class diagnostic models, ResNext50_32x4d was determined to be the optimal model, with accuracies of 86.7%, 82.1%, and 80.6% in the training, test, and validation sets, respectively. Six radiologists with varying levels of diagnostic experience (designed as Radiologist A through Radiologist F) achieved accuracies of 61.2%, 66.3%, 72.1%, 77.9%, 80.1% and 83.2% in thevalidation set, respectively. The optimal model showed better consistency with the diagnostic outcomes of the two senior radiologists, with intraclass correlation coefficients (ICC) of 0.735 and 0.862, respectively. <b>Conclusions</b>The developed 2.5D CNN model based on multi-sequences MRI has good classification and prediction performance in the differential diagnosis of meningiomas, providing valuable reference for distinguishing meningiomas from other brain tumors. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Comparative study of myocardial mechanical function changes before and after coronary artery bypass grafting using cardiac magnetic resonance feature tracking technique]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.005</link>
<description><![CDATA[<b>Objective</b>To explore the application value of cardiac magnetic resonance imaging feature tracking (CMR-FT) technology inassessing the changes in myocardial mechanical function before and after coronary artery bypass grafting (CABG) in patients. <b>Materials and Methods</b>A total of 35 patients with coronary heart disease (CHD) who underwent coronary artery bypass grafting were selected, and 35 healthy volunteers were recruited as a control group. Both groups underwent CMR-FT examination, with myocardial mechanical function measured using united imaging healthcare<sup><sup>,</sup></sup>s artificial intelligence technology and manually calibrated. CMR-FT was used to analyze the myocardial mechanical function of the left ventricle and obtain relevant parameters. To analyze the normality of variables using the Shapiro-Wilk test, variables that do not follow a normal distribution (circumferential displacement, circumferential velocity, circumferential strain rate, short-axis radial displacement, short-axis radial strain rate, longitudinal velocity, longitudinal strain rate, and longitudinal radial strain rate) should undergo the Wilcoxon rank-sum test for inter-group differences. Variables that follow a normal distribution (circumferential strain, short-axis radial velocity, short-axis radial strain, longitudinal displacement, longitudinal strain, long-axis radial displacement, long-axis radial velocity, and long-axis radial strain) should undergo the paired-samples <i>t</i>-test for inter-group differences. <b>Results</b>In the comparison between pre- and post-CABG patients, short-axis radial strain, longitudinal strain, and long-axis radial strain were significantly greater before surgery than after, with statistical significance (<i>P </i>&lt; 0.05). In the comparison between post-CABG patients and the normal control group, circumferential strain, short-axis radial strain, short-axis radial strain rate, longitudinal strain, long-axis radial velocity, and long-axis radial strain were significantly greater in the control group than in post-operative patients, with statistical significance (<i>P </i>&lt; 0.05). The results indicate that there has been no significant improvement in myocardial mechanical function following the surgery. <b>Conclusions</b>CMR-FT can accurately assess changes in myocardial mechanical function in patients before and after CABG,It has important clinical significance for guiding personalized treatment and improving patient prognosis. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application value of radiomics based on DCE-MRI combined with DKI in predicting triple-negative breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.006</link>
<description><![CDATA[<b>Objective</b>To construct a radiomics model based on dynamic contrast-enhanced MRI (DCE-MRI) and diffusion kurtosis imaging (DKI), and evaluate its diagnostic value for triple-negative breast cancer (TNBC). <b>Materials and Methods</b>A retrospective analysis was performed on the clinical data of 165 breast cancer patients, who were divided into a non-TNBC group (120 cases) and a TNBC group (45 cases) based on pathological results. All patients underwent preoperative DCE-MRI and DKI scans. The patients were randomly split into a training set (<i>n </i>= 132) and a test set (<i>n </i>= 33) at a ratio of 8∶2. A three-dimensional (3D) region of interest (ROI) was delineated in the lesion area from the phase Ⅱ DCE-MRI images, the mean kurtosis (MK) map, and the mean diffusivity (MD) map, and radiomics features were extracted. Feature reduction and selection were performed using K-best, maximum relevance and minimum redundancy (mRMR), and least absolute shrinkage and selection operator (LASSO) algorithms. Logistic regression (LR) classifiers were used to build the phase Ⅱ DCE model, DKI parameter map models (MD, MK, MD+MK), and the combined model (DCE-MRI+MD+MK). The stability of the models was validated using five-fold cross-validation. The models<sup><sup>,</sup></sup> predictive performance was evaluated by receiver operating characteristic (ROC) curve and area under the curve (AUC), and statistical differences between models were analyzed using the DeLong test. Finally, decision curve analysis (DCA) was performed to assess the clinical utility of the radiomics models. <b>Results</b>A total of 2286 radiomics features were extracted from the 3D ROIs of each sequence. From the Phase Ⅱ DCE-MRI, MD+MK, MD, MK, and DCE-MRI+MD+MK sequences, 8, 9, 12, 7, and 21 features were selected, respectively, that were associated with TNBC. The AUCs of the Phase Ⅱ DCE-MRI model, MD+MK model, MD model, and MK model in the test set were 0.810, 0.769, 0.676, and 0.625, respectively. The combined model (DCE-MRI+MD+MK) achieved an AUC of 0.884 in the test set, with an accuracy, sensitivity, and specificity of 78.8%, 79.2%, and 77.8%, respectively. Finally, a nomogram model was developed by integrating clinical features with radiomics features. The results indicated that the radiomics combined model (DCE-MRI+MD+MK) outperformed the MD+MK model, MD model, MK models, and Phase Ⅱ DCE-MRI model, but there was no statistically significant difference in AUC and DCA between the combined model and the nomogram model (<i>P</i> &gt; 0.05), suggesting that the radiomics combined model (DCE-MRI+MD+MK) can provide diagnostic performance similar to that of the nomogram model in clinical practice. <b>Conclusions</b>The radiomics combined model (DCE-MRI+MD+MK) based on DCE-MRI and DKI parameter maps, as well as the nomogram model, can effectively predict TNBC preoperatively, helping clinicians in diagnosing TNBC, formulating treatment plans, and improving prognosis. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of Gd-EOB-DTPA-enhanced MRI radiomics in predicting Glypican-3 positive expression in hepatocellular carcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.007</link>
<description><![CDATA[<b>Objective</b>To investigate the radiomics prediction of Glypican-3 (GPC3) positive expression in hepatocellular carcinoma (HCC) based on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) MRI. <b>Materials and Methods</b>The clinical indicators, MRI plain scan and enhanced imaging data of 126 HCC patients with GPC3 positive (77 cases) and negative (49 cases) in the First Affiliated Hospital of Suzhou University from January 2016 to June 2023 were retrospectively collected and analyzed. The clinical indicators included age, gender, hepatitis B infection, hepatitis B core antibody, alpha-fetoprotein (AFP), carbohydrate antigen 199 (CA199), carbohydrate antigen 125 (CA125). The patients received hepatectomy or needle biopsy, and Gd-EOB-DTPA MRI was performed within one month before the operation. Manually delineate the three-dimensional volume of interest of the lesion on five sequences of arterial phase AP, portal venous phase PVP, transitional phase TP, hepatobiliary phase HBP, and T2 weighted imaging T2WI in the transverse axis of MRI images, and extract the radiomics features of the lesion. After Pearson correlation analysis feature screening, the least absolute shrinkage and selection operator (LASSO) regression feature dimensionality reduction was performed to construct logistic regression models for clinical indicators, single sequences, and multiple sequences. Clinical indicators were combined with feature subsets from multiple sequence omics to construct a comprehensive nomogram for predicting GPC3 positive expression in HCC. Perform calibration curves to validate the comprehensive model of clinical indicators combined with multi-sequence omics, and use decision curve analysis to evaluate clinical utility. <b>Results</b>The infection of AFP and hepatitis B in the clinical indicators was independently related to the positive expression of GPC3. The area under the receiver operating characteristic curve (AUC) for the clinical indicator model training set is 0.827 (95% <i>CI</i>: 0.742 to 0.913), while the AUC for the test set is 0.779 (95% <i>CI</i>: 0.632 to 0.925). The radiomics models based on single-sequence MRI, including AP, PVP, TP, HBP, and T2WI sequences, demonstrate moderate predictive performance, with AUC values for the training set of 0.804 (95% <i>CI</i>: 0.713 to 0.894), 0.801 (95% <i>CI</i>: 0.711 to 0.892), 0.796 (95% <i>CI</i>: 0.706 to 0.887), 0.761 (95% <i>CI</i>: 0.660 to 0.863), 0.733 (95% <i>CI</i>: 0.620 to 0.845), respectively. The AUC values for the test set are 0.724 (95% <i>CI</i>: 0.555 to 0.894), 0.755 (95% <i>CI</i>: 0.597 to 0.912), 0.770 (95% <i>CI</i>: 0.619 to 0.920), 0.782 (95% <i>CI</i>: 0.610 to 0.947), 0.730 (95% <i>CI</i>: 0.561 to 0.900), respectively. The multi-sequence MRI radiomics model has an AUC value of 0.930 (95% <i>CI</i>: 0.879 to 0.981) for the training set and 0.870 (95% <i>CI</i>: 0.751 to 0.989) for the test set. The combined clinical indicators and multi-sequence radiomics comprehensive model shows good predictive performance, with an AUC value of 0.958 (95% <i>CI</i>: 0.919 to 0.997) for the training set and 0.903 (95% <i>CI</i>: 0.808 to 0.998) for the test set, a sensitivity of 86.4%, and a specificity of 86.7%. The calibration curve showed that the predicted GPC3 status was in good consistency with the actual GPC3 states. Decision curve analysis shows that the comprehensive model has good clinical practicality. <b>Conclusions</b>A preoperative comprehensive nomogram based on clinical indicators and multi-sequence MRI radiomics can non-invasively and effectively predict GPC3 positive expression in HCC. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Development and validation of a model for predicting pathological grade of intrahepatic mass-forming cholangiocarcinoma based on intratumoral and peritumoral features on MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.008</link>
<description><![CDATA[<b>Objective</b>To explore the value of intratumoral and different peritumoral radiomics features based on T2-weighted imaging (T2WI) and diffusion weighted imaging (DWI), as well as clinical imaging factors, in preoperative prediction of the pathological grade of intrahepatic mass-forming cholangiocarcinoma (IMCC). <b>Materials and Methods</b>A retrospective analysis was conducted on the clinical and preoperative MRI data of 197 patients with IMCC confirmed by postoperative pathology. The region of interest (ROI) of the tumor was delineated on axial T2WI and DWI images, and extended outward by 3 mm, 5 mm, 10 mm, 15 mm, and 20 mm respectively to obtain peritumoral ROIs of different ranges. Radiomics features were extracted by PyRadiomics. Features were screened through homogeneity of variance test, independent sample <i>t</i>-test, recursive feature elimination algorithm and least absolute shrinkage and selection operator. Logistic regression (LR) classifier and 5-fold cross-validation method were used for modeling and verification. Clinical imaging model, intratumoral omics model, peritumoral omics model, intratumoral + peritumoral omics model, dual-sequence fusion model and multimodal combined model were established. The predictive efficacies of each of the above models were compared to select the best model. Receiver operating characteristic (ROC) curve and area under the curve (AUC) were used to evaluate the performance of the model. DeLong test was used to compare the differences in AUC. Calibration curve was used to evaluate the fitting ability of the model, and decision curve was used to assess the clinical value of the model. <b>Results</b>In the peritumoral omics models, the DWI 3 mm model shows the best performance, with AUCs of 0.836 and 0.777 in the training set and validation set respectively. Gender, age, lesion location, and vascular involvement are independent predictors of the pathological grade of IMCC. The AUCs of the clinical imaging model in the training set and validation set are 0.658 and 0.614 respectively. The intratumoral + 3 mm peritumoral 3 mm model has the best predictive efficacy, with AUCs of 0.892 and 0.814 in the training set and validation set respectively, which is superior to the dual-sequence fusion model and the multimodal combined model. <b>Conclusions</b>The intratumoral + 3 mm peritumoral radiomics model based on DWI sequence shows the best predictive ability. It can noninvasively predict the pathological grade of IMCC before surgery and provide theoretical guidance for clinical treatment decisions. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of quantitative parameters of diffusion kurtosis imaging in preoperative prediction of tumor budding grade of rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.009</link>
<description><![CDATA[<b>Objective</b>To investigate the value of multiple quantitative parameters of magnetic resonance diffusion kurtosis imaging (DKI) in predicting tumor budding (TB) grade of rectal cancer. <b>Materials and Methods</b>Retrospective analysis of data from 113 patients with rectal adenocarcinoma who underwent preoperative 3.0 T MR examination and were confirmed by surgical pathology, including 75 patients in low-medium grade TB group and 38 patients in high grade TB group<b>. </b>The diffusion weighted imaging (DWI) and DKI quantitative parameter values of the lesions in two groups were recorded, including the apparent diffusion coefficient (ADC) value, fractional anisotropy (FA) value, mean diffusivity (MD) value, mean kurtosis (MK) value. The intra-class correlation coefficient (ICC) test was used to evaluate the measurement consistency of each parameter value between two observers. The independent samples <i>t</i>-test or Mann-Whitney <i>U</i> test was used to analyze the differences between the two groups of parameters, and the diagnostic performances of single parameter and combined parameters were evaluated through the receiver operating characteristic (ROC) curve. The DeLong test was used to compare the performance of each parameter. <b>Results</b>The agreement between the two observers for each parameter value was good (ICC &gt; 0.75). The MK value of the low-medium grade group was 0.762 ± 0.127, which was lower than the high grade group with the value of 0.962 ± 0.120. The ADC and MD values of the low-medium grade groups were 1.157 (1.043, 1.317) × 10<sup>-3</sup> mm<sup>2</sup>/s and (1.377 ± 0.265) μm<sup>2</sup>/ms, which were all higher than those of the high grade group with the value of 0.964 (0.869, 1.069) × 10<sup>-3</sup> mm<sup>2</sup>/s and (1.114 ± 0.135) μm<sup>2</sup>/ms, respectively, the difference of each parameter was statistically significant (<i>P </i>&lt; 0.05). There was no statistically significant difference in FA values between the two groups. The areas under the curve (AUC) of ADC, MD and MK values in predicting TB grade were 0.805, 0.816, 0.880, with the sensitivities of 73.7%, 92.1%, 76.3%, and the specificities of 78.7%, 68.0%, 86.7%, respectively. The diagnostic performance of MK value was better than ADC and MD values (<i>P </i>&lt; 0.05). The AUC values of the combined parameters ranged from 0.826 to 0.881, and there was no statistically significant difference in AUC value compared to the MK value. <b>Conclusions</b>The DKI quantitative parameters MK and MD demonstrated significant utility in the non-invasive preoperative prediction of TB status in rectal cancer, thereby assisting clinicians in formulating tailored treatment strategies for patients. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application value of pCASL technique in assessing renal function impairment and staging in chronic kidney disease patients with hypertension]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.010</link>
<description><![CDATA[<b>Objective</b>To investigate the value of applying pseudo continuous arterial spin labeling (pCASL) on renal impairment and staging in chronic kidney disease (CKD) patients with or without hypertension. <b>Materials and Methods</b>Twenty healthy volunteers (HV), 34 non- hypertension CKD patients (CN), and 36 hypertension CKD patients (CH) were prospectively analyzed. The CKD patients were further categorized into stage 1-2 and stage 3-5 patients based on estimated glomerular filtration rate (eGFR). Subjects completed pCASL scans, and cortical and medullary renal blood flow (cRBF and mRBF) were measured. Differences in right and left side renal renal blood flow (RBF) values, cRBF and mRBF values were compared separately using paired <i>t</i>-tests. Adjusting for age and body mass index (BMI) as covariates, differences in RBF values between subgroups were compared using covariance (ANCOVA) test. The diagnostic value of renal RBF values for renal injury was analyzed using the receiver operating characteristic (ROC) curve. Spearman<sup><sup>,</sup></sup>s correlation analysis was used to assess the correlation between renal function indexes and RBF values in CKD patients. <b>Results</b>There was no statistically significant difference between the RBF values of the left and right side kidneys (<i>P</i> &gt; 0.05), and the cRBF values of the kidneys in all three groups was greater than the mRBF values (<i>P</i> &lt; 0.05). The overall difference in the RBF values of the HV group, the CN 1-2 stage group, and the CN 3-5 stage group was statistically significant (cRBF: <i>F </i>= 18.423, <i>P </i>&lt; 0.001; mRBF: <i>F</i> = 12.026, <i>P </i>&lt; 0.001), and further two-by-two intergroup comparisons using Bonferroni method showed that except the mRBF values of HV group and CN 1-2 were not statistically significant (<i>P</i> &gt; 0.05), the differences among other subgroups were statistically significant (<i>P</i> &lt; 0.05); the overall difference in RBF values between the HV, CH 1-2 and CH 3-5 stage group was also statistically significant (cRBF: <i>F </i>= 12.452, <i>P </i>&lt; 0.001; mRBF: <i>F </i>= 16.153, <i>P </i>&lt; 0.001). The RBF values of the HV group and the CH 1-2 stage group were also higher than those of the CH 3-5 stage group. The differences in RBF values between the HV group and CH 1-2 group were not statistically significant (<i>P</i> &gt; 0.05). cRBF and mRBF differentiated between HV and CN with AUCs of 0.794 and 0.715, sensitivities of 52.90% and 41.20%, and specificities of 95.00% and 100.00%; whereas differentiated between HV and CH with AUCs of 0.740 and 0.726, sensitivities of 58.30% and 47.20%, and specificities of 85.00% and 100.00%. Correlation analysis showed that all RBF values were positively correlated with eGFR and negatively correlated with serum creatinine and CKD stage. <b>Conclusions</b>pCASL can be used to diagnose CKD and provide a new imaging reference index for the staging of the disease, in which the perfusion indexes in patients with combined hypertension have a better correlation with the renal function indexes, suggesting that the factor of the presence or absence of hypertension should be considered when applying pCASL to quantify the renal perfusion values. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Study on the diagnostic value of combined models based on PSAD and mp-MRI in clinically significant prostate cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.011</link>
<description><![CDATA[<b>Objective</b>To evaluate the value of prostate specific antigen density (PSAD) combined with multi-parameter magnetic resonance imaging (mp-MRI) used in diagnosing clinically significant prostate cancer (csPCa). <b>Materials and Methods</b>Retrospective analysis of clinical and imaging data of 105 patients with suspected PCa and pathological findings were selected, prostate specific antigen (PSA) detection and mp-MRI were performed before surgery. Based on pathological results and Gleason score, patients were divided into csPCa and non-csPCa groups. Parameters of mp-MRI including apparent diffusion coefficient (ADC), Begin time of enhancement (T0), Brevity of enhancement, wash in rate (WIR) and PSAD were compared between the two groups, combined diagnostic models were constructed by binary logistic regression, and receiver operating characteristic (ROC) curves were used to evaluate the diagnostic efficacy of each parameter and model for csPCa. <b>Results</b>The ADC and T0 in csPCa group were lower than those in non-csPCa group, while the PSAD, WIR and Brevity of enhancement were opposite, and all differences reach statistical significance (<i>P </i>&lt; 0.05). The area under the curve (AUC) for the diagnosis of csPCa in PSAD, ADC and WIR were 0.902 (0.829 to 0.952), 0.890 (0.814 to 0.942) and 0.812 (0.724 to 0.882) respectively with higher diagnostic efficacy, the clinical diagnostic boundaries were 0.47 ng/(mL·cm<sup>3</sup>), 0.82 × 10<sup>-3</sup> mm<sup>2</sup>/s, 50.33 s<sup>-1</sup>, the sensitivities were 79.1%, 67.4%, 100.0%, and the specificities were 100.0%, 100.0% and 54.8%, respectively. The AUC, sensitivity and specificity of any two and multi-parameter combined diagnosis of csPCa by WIR, PSAD and ADC: WIR + PSAD 0.929 (0.862 to 0.970), 83.7%, 96.8%; ADC + PSAD 0.940 (0.877 to 0.977), 90.7%, 91.9%; WIR + ADC 0.935 (0.870 to 0.974), 79.1%, 95.2%; WIR + PSAD + ADC 0.955 (0.896 to 0.986), 90.7%, 91.9%, respectively. ROC curve contrast analysis revealed significant differences in AUC between WIR + PSAD + ADC, ADC + PSAD, WIR + ADC combined diagnostic models and ADC, WIR single parameter diagnosis of csPCa (<i>P </i>&lt; 0.05); the AUC of WIR+PSAD model was different from that of WIR in the diagnosis of csPCa statistically (<i>P </i>&lt; 0.05). <b>Conclusions</b>PSAD combined with mp-MRI has a high diagnostic value for csPCa, progressively, the combined diagnostic model based on the key indicators can be used to predict csPCa. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Study the value of reduced field-of-view diffusion kurtosis imaging in histological evaluation of endometrial adenocarcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.012</link>
<description><![CDATA[<b>Objective</b>To explore the potential performance of reduced field-of-view diffusion kurtosis imaging (rFOV-DKI) in the differentiating the different histological grades of endometrial adenocarcinoma. <b>Materials and Methods</b>A total of 48 patients with pathologically confirmed endometrial adenocarcinoma were enrolled in our study after getting institutional review board approval. According to the two-rank classification method of the International Federation of Gynecology and Obstetrics (FIGO), the participants were divided to low-grade group (G1, G1-2 and G2, <i>n </i>= 30) and high-grade group (G3, <i>n </i>= 18). All participants underwent contrast enhancement MR examinations including routine sequences and additional rFOV-DKI sequence on a 3.0 T MRI scanner. The data was postprocessed by the functional tool on the workstation (AW4.6, GE Healthcare). With the reference of sagittal T2WI images, the lesion ROI (region of interest) was outlined. Derived parameters of DKI, including mean diffusivity (MD), axial diffusivity (Da), radial diffusivity (Dr), mean kurtosis (MK), axial kurtosis (Ka), and radial kurtosis (Kr) were all calculated. The DKI parameters of low-grade group and high-grade group were compared. The receiver operating characteristic (ROC) curve was used to evaluate each parameter<sup><sup>,</sup></sup>s diagnostic performance. <b>Results</b>Mean values of MD, Da and Dr of low-grade group [(0.93 ± 0.08) µm<sup>2</sup>/ms, (1.14 ± 0.10) µm<sup>2</sup>/ms, (0.83 ± 0.08) µm<sup>2</sup>/ms] were significantly higher than those of high-grade group [(0.80 ± 0.08) µm<sup>2</sup>/ms, (1.05 ± 0.07) µm<sup>2</sup>/ms, (0.74 ± 0.06) µm<sup>2</sup>/ms; all <i>P</i> &lt; 0.05]. While mean values of MK, Ka and Kr of low-grade group (1.15 ± 0.10, 1.36 ± 0.10, 0.97 ± 0.13) were significantly lower than those of high-grade group (1.33 ± 0.11, 1.64 ± 0.11, 1.08 ± 0.09). The Ka values had the highest diagnostic accuracy in differentiating low-grade group from high-grade group, AUC = 0.98 (95% <i>CI</i>: 0.89 to 1.00), followed by MK [AUC = 0.90 (95% <i>CI</i>: 0.78 to 0.97)] and MD [AUC is 0.88 (95% <i>CI</i>: 0.76 to 0.96)]. There were no significant differences between AUCs of MK and Ka (<i>Z </i>= 1.81, <i>P </i>= 0.07), and AUCs of MK and MD (Z = 0.53, <i>P</i> = 0.59), while significant differences were found between that of Ka and MD (<i>Z</i> = 2.40, <i>P</i> = 0.02). Ka performed best (sensitivity: 100%, specificality: 90%) in the differentiation between low-grade group from high-grade group among all DKI derived parameters. <b>Conclusions</b>Kurtosis indices from rFOV-DKI based on the non-Gaussian diffusion-weighted model can be acted as a potential tool in the grade differentiation of endometrial adenocarcinoma, and can be a useful compensation to the conventional MRI. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[A comparative study of MRI-based methods for quantitative assessment of skeletal muscle fat content]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.013</link>
<description><![CDATA[<b>Objective</b>The proton density fat fraction (PDFF) was used as a reference to analyze and compare the difference and consistency between PDFF and visual scoring method, in phase and out of phase method, and threshold segmentation method in quantifying fat infiltration of lumbar paraspinal muscles. <b>Materials and methods</b>A total of 227 patients who underwent lumbar MRI examination from January 2023 to December 2023 were collected, and the scanning sequences included T2WI, iterative Dixon water-fat separation with echo asymmetry and least-squares estimation, and iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantitation. Fat content of the paraspinal muscles was quantitatively assessed using Goutallier classification (GC), fat fraction (FF), the percentage of fat infiltration area (%FIA) and PDFF, respectively. Intra-class correlation coefficient (ICC), Mann-Whitney <i>U</i> test, Bland-Altman bias and Spearman correlation were used to evaluate the agreement, difference, bias and correlation between PDFF and GC, FF and %FIA. <b>Results</b>Among the four imaging methods, GC had the worst consistency (ICC = 0.623, <i>P </i>&lt; 0.001), and %FIA had the best consistency (ICC = 0.965, <i>P </i>&lt; 0.001). The measurement results of FF, %FIA and PDFF are different (all <i>P </i>&lt; 0.05) and biased. There was a weak correlation between GC and PDFF (<i>r </i>= 0.252 to 0.367, all <i>P </i>&lt; 0.001). There was no correlation between FF and PDFF in multifidus muscle (all <i>P </i>&gt; 0.05). %FIA was moderately correlated with PDFF (<i>r </i>= 0.546 to 0.652, all <i>P </i>&lt; 0.001). <b>Conclusions</b>The reliability of GC is general, and the accuracy of FF is low. %FIA is highly correlated with PDFF and stable. The threshold segmentation method can be used as an alternative method for PDFF. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Quantitative assessment of three-dimensional ultrashort echo time adiabatic T1ρ imaging in articular cartilage degeneration]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.014</link>
<description><![CDATA[<b>Objective</b>To quantitatively evaluate articular cartilage degeneration using three-dimensional ultrashort-echo-time Adiabatic-T1ρ (3D UTE-AdiabT1ρ) imaging and improve magnetic resonance technique for the early quantitative evaluation of osteoarthritis (OA). <b>Materials and Methods</b>The knee joint scanning was performed in 20 healthy volunteers and 40 OA patients with different degrees of OA using 3D UTE-AdiabT1ρ sequence and Cones data collection. The knee cartilages were divided into 13 subregions slice by slice on sagittal fat suppression images of T2WI and Whole-Organ Magnetic Resonance Imaging Score (WORMS) were performed by two musculoskeletal radiologists. WORMS includes 0, 1, 2, 2.5, 3, 4, and 5 points. According to the extent of lesions, they were divided into localized lesion group (WORMS = 1, 2, 2.5 points) and diffuse lesion group (WORMS = 3, 4, 5 points). According to the depth of lesions, they were divided into partial layer lesions (WORMS = 1, 2, 3, 4 points) and full layer lesions (WORMS = 2.5, 5 points). The differences in UTE-Cones-AdiabT1ρ among different groups based on WORMS were assessed and compared using one-way analysis of variance (ANOVA) and Tukey-Kramer test. The correlations between UTE-Cones-AdiabT1ρ, UTE-T1 and WORMS were evaluated using Spearman<sup><sup>,</sup></sup>s correlation coefficient. Receiver operating characteristic (ROC) was used to evaluate the diagnostic efficacy of UTE-Cones-AdiabT1ρ for the detection of earl cartilage degeneration (WORMS = 1). The DeLong test was used to compare the area under the curve (AUC) of UTE-Cones-AdiabT1ρ, UTE macromolecular fraction (MMF) and magnetization transfer ratio (MTR). <b>Results</b>The UTE-Cones-AdiabT1ρ from 0 to 5 points of WORMS were 36.6 ms, 41.7 ms, 42.7 ms, 45.0 ms, 43.2 ms, 44.3 ms, and 47.9 ms, respectively. UTE-Cones-AdiabT1ρ in localized lesion group was 42.0 ms, with 44.3 ms in diffuse lesion group, 42.5 ms in partial layer lesions, and 46.9 ms in full layer lesions. The higher UTE-Cones-AdiabT1ρ values were observed in higher WORMS, also in larger and deeper lesions, and the differences among these groups were statistically significant (<i>F </i>= 159.7, <i>P </i>&lt; 0.001; <i>F </i>= 423.6, <i>P </i>&lt; 0.001; <i>F </i>= 466.3, <i>P </i>&lt; 0.001). The 3D UTE-Cones-AdiabT1ρ values of different cartilage subregions were different when WORMS=0. 3D UTE-Cones-AdiabT1ρ values were positively correlated with WORMS, lesion ranges and depths (<i>r </i>= 0.55, <i>P </i>&lt; 0.001; <i>r </i>= 0.53, <i>P </i>&lt; 0.001; <i>r </i>= 0.55, <i>P </i>&lt; 0.001), and UTE-T1 values was positively correlated with WORMS (<i>r </i>= 0.27, <i>P </i>&lt; 0.001). The diagnostic threshold of 3D UTE-Cones-AdiabT1ρ for early cartilage degeneration (WORMS = 1) was 39.4 ms, diagnostic sensitivity was 70.9%, and specificity was 69.3%. The AUC of 3D UTE-Cones-AdiabT1ρ in the diagnosis of early cartilage degeneration (WORMS = 1) was 0.76 (95% <i>CI</i>: 0.74 to 0.78), which was similar to that of UTE-MMF (AUC = 0.74; <i>Z </i>= 1.47, <i>P </i>= 0.142) and higher than that of UTE-MTR (AUC = 0.62; <i>Z </i>= 8.67, <i>P </i>&lt; 0.001). <b>Conclusions</b>The 3D UTE-Cones-AdiabT1ρ sequence can be useful in quantitative evaluation of articular cartilage degeneration. It has the clinical value of early diagnosis of OA. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Quantitative assessment of articular cartilage in the foot and ankle of amateur marathon runners by T2<sup>*</sup> mapping and analysis of its related influencing factors]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.015</link>
<description><![CDATA[<b>Objective</b>Quantitative analysis of T2<sup>*</sup> values of articular cartilage in the foot and ankle of amateur marathon runners based on T2<sup>*</sup> mapping, and analysis of their relationship with gender, age, body mass index (BMI), running age, and running volume. <b>Materials and Methods</b>From July 2023 to September 2023, 48 long-distance runners in Chongqing were recruited according to the inclusion and exclusion criteria of this study, including 36 cases with running distance volume &lt; 300 km/month (low to medium running volume group) and 12 cases with running distance volume ≥ 300 km/month (high running volume group). The unilateral asymptomatic ankle joints of all subjects were scanned using MRI, and the scanning sequences included T2<sup>*</sup> mapping multi-echo spine cho (SE) sequence sagittal, proton density-weighted imaging fat-saturated (PDWI-FS) sequence sagittal, coronal, transverse axial, and T1-weighted imaging fat-saturated (T1WI-FS) sequence transverse axial. The cartilage of the talar dome, the calcaneal surfaces and cuboid surfaces of the calcaneocuboid joint, the calcaneal surfaces and talar surfaces of the posterior subtalar joint were outlined as regions of interest (ROI) along the edges of the articular cartilage contour, and the corresponding T2<sup>*</sup> values were obtained. Analyze the relationship between the T2<sup>*</sup> values of cartilage and age, BMI, running age with multiple linear regression, and running volume, gender with independent samples <i>t</i>-test. <b>Results</b>(1) The differences of cartilage T2<sup>*</sup> values of the talar dome, the calcaneal surfaces and cuboid surfaces of the calcaneocuboid joint, the calcaneal surfaces and talar surfaces of the posterior subtalar joint were statistically significant in gender (<i>P </i>= 0.001, <i>P </i>&lt; 0.001, <i>P </i>= 0.002, <i>P </i>= 0.008, <i>P </i>= 0.004). (2) The T2<sup>*</sup> values of cartilage of the talar dome and calcaneal surface of posterior subtalar joint of high running group were higher than those of low to medium running group (<i>P </i>= 0.014, 0.023), the differences in T2<sup>*</sup><i> </i>values of cartilage of the calcaneal surface and cuboid surface of the calcaneocuboid joint, and the talar surface of the posterior subtalar joint were not statistically significant among the different running group (<i>P </i>= 0.987, 0.072, 0.724). (3) T2<sup>*</sup> values of cartilage in the talar dome, the calcaneal surfaces and the cuboid surfaces of the calcaneocuboid joint, the calcaneal surfaces and the talar surfaces of the posterior subtalar joint are positively correlated with BMI (<i>r</i> = 0.376, 0.384, 0.300, 0.422, 0.455; <i>P </i>= 0.005, 0.004, 0.019, 0.001, 0.001). <b>Conclusions</b>In amateur marathoners, high running volume is more likely to result in cartilage injuries to the talar dome, the calcaneal surfaces of the posterior subtalar joint compared with low running volume; whereas high BMI increase the risk of cartilage injuries to the talar dome, heel facet of the calcaneus and dice joints, and cartilage injuries to the talar dome, the calcaneal surfaces and cuboid surfaces of the calcaneocuboid joint, the calcaneal surfaces and talar surfaces of the posterior subtalar joint, compared with lower BMI. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[An experimental study of 3.0 T magnetic resonance imaging to evaluate autoimmune prostatitis in rats]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.016</link>
<description><![CDATA[<b>Objective</b>To explore the application value of 3.0 T MRI in evaluating the severity of experimental autoimmune prostatitis (EAP) and the effect of zinc supplementation in rats. <b>Materials and Methods</b>This study was a prospective randomized controlled experiment, and five groups of rat models were constructed based on the traditional modeling method of autoimmune prostatitis rats, which were normal control (NC) group (6 rats), model group A (EAP-A group) (6 rats), treatment group A (EAPZ-A group) (6 rats), model group B (EAP-B group) (6 rats), and treatment group B (EAPZ-B group) (6 rats). Among them, the rats in the EAP-A group and the EAPZ-A group were modeled by intradermal injection of 15 mg/mL allogeneic prostate antigen mixture, the rats in the EAP-B group and the EAPZ-B group were modeled by intradermal injection of 30 mg/mL allogeneic prostate antigen mixture, and the rats in the NC group were modeled by intradermal injection of the same amount of normal saline. MRI scans were performed before the model was constructed (12 weeks old), after the model was constructed (18 weeks old) and after the treatment group was supplemented with zinc (22 weeks old), including axial T1WI, T2WI, diffusion weighted image (DWI) and sagittal proton density-weighted imaging (PDWI). At the end of the 22-week-old scan, the samples were collected and observed by pathological staining of hematoxylin-eosin (HE). The standardized T2WI signal intensity and average diffusion coefficient (ADC) values of the prostate gland at different weeks in each group were measured, and the prostate was compared between and within groups. Among them, one-way ANOVA was used to compare the standardized T2WI signal intensity of the prostate gland at different weeks in each group, and the least significant difference (LSD) was further compared when <i>P </i>&lt; 0.05. The paired <i>t</i>-test was used for intra-group comparison of standardized T2WI signal intensity of rat prostate at different weeks of age in each group. One-way ANOVA was used to compare the ADC values of the prostate gland at different weeks in each group. The paired <i>t</i>-test was used for intra-group comparison of ADC values of prostate at different weeks in each group. <b>Results</b>At 12 weeks of age, there was no statistically significant difference in the intensity of standardized T2WI signal between the groups (<i>P </i>= 0.918). After successful modeling at 18 weeks of age, except for the NC group, the standardized T2WI signal intensity in the other four groups decreased to varying degrees, and the standardized T2WI signal intensity in the EAP-A group/EAPZ-A group was higher than that in the EAP-B group/EAPZ-B group (all<i> P </i>&lt; 0.001), but there was no significant difference between EAP-A and EAPZ-A and EAPZ-B and EAPZ-B (<i>P</i> values were 0.340 and 0.113, respectively). After the end of treatment at 22 weeks, the standardized T2WI signal intensity in EAPZ-A and EAPZ-B groups rebounded, and the difference was not statistically significant (all<i> P </i>&gt; 0.05), and they were all higher than those in EAP-A and EAP-B (all<i> P</i> &lt; 0.001). There was no significant difference in the ADC values between groups and within groups at different weeks (all <i>P </i>&gt; 0.05). <b>Conclusions</b>3.0 T MRI can effectively assess the severity of EAP in rats, and can be used as a non-invasive means to monitor the effect of zinc supplementation, which has important clinical application potential. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Evaluation of type-H vessels in bone marrow of type 1 diabetic rabbits based on ultra-small superparamagnetic nano-iron oxide enhanced MRI]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.017</link>
<description><![CDATA[<b>Objective</b>To explore the feasibility of quantitative and visual targeting evaluation of type-H vessel structure in bone marrow of rabbits with type 1 diabetes mellitus (T1DM) based on ultra-small superparamagnetic nano-iron oxide (USPIO) enhanced MRI combined with in vitro micro-computed tomography (Micro-CT) microangiography. <b>Materials and Methods</b>T1DM rabbits were constructed by injecting alloxan into the auricular vein in 20 out of 40 Japanese white rabbits (2-3 month-old). The remaining rabbits received equivalent volumes of normal saline via auricular marginal vein injection as controls. After 4 months of successful modeling, samples from metaphyseal and diaphyseal parts of tibia were taken respectively for sorting and identification of bone marrow Type-H vascular endothelial cells, Type-H vascular immunofluorescence detection, USPIO labeling of bone marrow endothelial cells in vitro and in vivo, MRI and Micro-CT microangiography of bone marrow in vitro. The proportion of Type-H vascular endothelial cells, average fluorescence intensity, T2 value of MRI, vessel volume/tissue volume (VV/TV) and vessel number (VN) were measured respectively. <b>Results</b>Compared with the control group, the proportion of type-H vascular endothelial cells, average fluorescence intensity, VV/TV and VN of bone marrow were significantly decreased in T1DM rabbits (<i>P </i>&lt; 0.05), and the T2 value of MRI in bone marrow showed significant differences before and after USPIO injection (<i>P </i>&lt; 0.05). The metaphyseal and diaphysis of T1DM rabbits were respectively compared with the control group. The proportion of type-H vascular endothelial cells, average fluorescence intensity, maximum change of T2 value and fastest time rate, VV/TV and VN in metaphysis were significantly different from those in the diaphysis (<i>P </i>&lt; 0.05). <b>Conclusions</b>USPIO enhanced MRI combined with in vitro Micro-CT microvascular imaging is feasible for quantitative and visual targeting evaluation of bone marrow type-H vascular structure in T1DM rabbits. This study provides imaging evidence for exploring diabetic bone marrow microangiopathy. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of fMRI in brain network remodeling and brain plasticity during stroke recovery]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.018</link>
<description><![CDATA[With the advancement of neuroimaging technology, non-invasive methods for studying the structure and function of the human brain have become increasingly diverse and multifaceted. Currently, by utilizing diverse connectomics approaches based on magnetic resonance data, researchers have elucidated abnormalities at various hierarchical and dimensional levels in central nervous system diseases. This has provided multifaceted scientific analyses and explanations for the pathogenesis of diseases, cognitive dysfunction, and the prediction and early intervention of diseases. However, current connectomics-based research predominantly focuses on either structure or function, lacking a systematic description that integrates both aspects. This limitation impedes a comprehensive understanding of the complexity of brain networks and the multidimensional impacts of neurological disorders. Therefore, this paper is to review the advancements in brain connectivity research within the context of central nervous system diseases, assist in the judicious selection of relevant techniques and methods and enhance the understanding of the structural and functional impairments associated with neurological disorders. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in structural-functional connectivity coupling analysis for understanding post-stroke functional impairments]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.019</link>
<description><![CDATA[As a prevalent neurological disorder, stroke can result in a variety of functional impairments, significantly impacting patients<sup><sup>,</sup></sup> quality of life. Structural connectivity (SC) and functional connectivity (FC), along with the SC-FC connectivity coupling analysis, have garnered considerable attention in the research of uncovering the neural mechanisms underlying post-stroke functional impairments. This review outlines the fundamental principles of SC-FC connectivity coupling analysis by summarizing the fundamentals of SC and FC and their mechanisms, and focus on the role of SC-FC connectivity coupling analysis applied to motor dysfunction, cognitive dysfunction, and mood disorders after stroke. By evaluating the coupling relationship between SC and FC, we can systematically analyze the potential neuroimaging features of the severity of dysfunction and rehabilitation potential. In turn, it can provide novel ideas for the personalized rehabilitation strategies for post-stroke patients. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress in multimodal MRI and imaging genetics in Parkinson<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.020</link>
<description><![CDATA[Parkinson<sup><sup>,</sup></sup>s disease (PD) is a complex chronic progressive neurodegenerative disorder, with genetic factors playing a significant role in its onset and progression. MRI is a non-invasive technique used to assess changes in brain structure and function. Imaging genetics combining genetic information with brain imaging data may explore the relationship between genes and brain phenotypes. This article reviews the research progress of multimodal MRI and imaging genetics in PD, aiming to provide neurobiological evidence for understanding the pathophysiological mechanisms, early diagnosis, personalized treatment and prognosis of PD. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of perfusion imaging in the treatment and prognosis assessment of ischemic stroke]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.021</link>
<description><![CDATA[Ischemic stroke is an acute cerebrovascular disease caused by various causes of brain blood supply disorders, resulting in brain tissue ischemia, hypoxic necrosis, and then corresponding neurological impairment symptoms. Morbidity, mortality and disability are high, and treatment options are limited. Perfusion imaging is an imaging method based on flow effect to observe molecular microscopic motion, which can measure the blood perfusion and microcirculation of local brain tissue, provide tissue hemodynamic information and analyze brain tissue activity, and has important reference value for clinical diagnosis and treatment. This paper systematically summarizes the application progress of various perfusion imaging technologies in ischemic stroke, fills the shortcomings of comprehensive analysis of these technologies in current studies, and provides the advantages and limitations of different perfusion imaging technologies for clinicians to help them achieve accurate treatment in patients with ischemic stroke. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of fMRI in brain plasticity during the rehabilitation period of hemiplegia after stroke]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.022</link>
<description><![CDATA[Stroke is one of the main causes of disability in the world, which can lead to motor, sensory and cognitive impairments in patients. Traditional rehabilitation treatment cycle is long and has slow effect. In recent years, the application of brain-computer interface, healthy cervical nerve transfer, brain stimulation and cell therapy in stroke patients is to enhance brain plasticity and relieve symptoms. Provides new treatment ideas for clinical practice. Functional magnetic resonance imaging (fMRI) is one of the important research tools in brain science and has been widely used in the research on stroke rehabilitation. It can not only describe functional and network connection changes, but also predict rehabilitation prognosis, guide treatment plans and monitoring the rehabilitation effect provides a theoretical basis for rehabilitation treatment of stroke. This review summarizes the exploration of the application of fMRI technology at home and abroad in recent years in brain network remodeling, analyzes relevant research results and existing difficulties, in order to provide new ideas for fMRI research on stroke rehabilitation treatment. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of blood-brain barrier evaluation methods based on arterial spin labeling in central nervous system diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.023</link>
<description><![CDATA[The blood-brain barrier (BBB) is a critical component of the neurovascular unit and is crucial for maintaining the stability of the central nervous system. Its dysfunction is associated with various neurological disorders. Arterial spin labeling (ASL) technology, a non-invasive magnetic resonance imaging (MRI) method, uses water protons as a natural endogenous tracer. By monitoring the exchange of ASL signals from microvessels to brain tissue, it assesses the functional status of the BBB. This article will discuss the application of three BBB assessment techniques based on ASL in Alzheimer<sup><sup>,</sup></sup>s disease (AD), sickle cell disease (SCD), demyelinating diseases, cerebral small vessel disease (CSVD), and schizophrenia spectrum disorder (SSD), with the aim of providing important references for researchers to use these techniques to study the functional impairment of BBB in central nervous system diseases. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the application of peritumoral radiomics in gliomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.024</link>
<description><![CDATA[Glioma represents the most prevalent primary intracranial neoplasm, and surgical resection constitutes the preferred primary therapeutic regimen. Approximately 90% of postoperative recurrences in glioma patients occur within the peritumoral brain zone (PBZ), which serves as the boundary between tumor tissue and adjacent normal brain tissue. The PBZ is a pivotal component of the tumor microenvironment and provides insights into the invasive behavior of glioma towards surrounding tissues. A comprehensive understanding and exploration of the biological information contained within the PBZ are crucial for improving the prognosis of glioma patients. In recent years, radiomics has made significant progress in applications such as glioma grading, genotyping, and prognostic evaluation, but primarily focusing on the solid component. As research advances, the importance of the PBZ in assessing the biological behavior of gliomas has gradually come to light, rendering radiomic studies of the PBZ a key area of investigation. This article reviews the concept and significance of the PBZ, along with the advancements in the utilization of peritumoral radiomics in gliomas, including differential diagnosis, molecular typing, prediction of postoperative recurrence and prognosis prediction. The objective is to enhance the understanding of PBZ in gliomas, provide insights and guidelines for conducting pertinent research, and ultimately establish a foundation for precise management strategies for patients. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of MRI machine learning in predicting the prognosis of pituitary neuroendocrine tumors]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.025</link>
<description><![CDATA[Pituitary neuroendocrine tumors (PitNETs) are mostly benign tumors, but pituitary dysfunction, tumor invasiveness, and the occurrence of various complications can significantly affect the quality of life of PitNETs patients, therefore, the non-invasive assessment of tumor prognosis is of great significance in clinical decision-making. MRI is the most commonly used examination method for PitNETs, and MRI machine learning have played an important role in the prognosis assessment of PitNETs. This review summarizes the research progress of MRI machine learning in predicting the chemotherapy prognosis, postoperative recurrence/remission, postoperative complications, and radiotherapy prognosis of PitNETs, with the aim of providing clinical guidance for individualized prognosis assessment and guiding future research. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in multi-sequence MRI for differentiating high-grade glioma and brain metastasis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.026</link>
<description><![CDATA[High-grade glioma (HGG) and brain metastasis (BM) are the two most common types of malignant intracranial tumors. Their treatment strategy and prognosis are different. Therefore, it is of great significance to differentiate HGG from BM preoperatively. This paper reviews the research progress of specific imaging signs on conventional MRI and the research progress of multiple functional MRI (fMRI) in the differential diagnosis of HGG and BM, in order to provide reference for clinical differential diagnosis and follow-up research. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress in radiomics for qualitative diagnosis of thyroid nodules]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.027</link>
<description><![CDATA[Thyroid nodule (TN) is one of the most common endocrine disorders, and its prevalence increases with age. Early differentiation of benign and malignant nodules is crucial for patient treatment and prognosis, and has significant clinical implications. Traditional imaging methods play an irreplaceable role in the diagnosis and evaluation of TN. However, due to their subjectivity, they often fail to provide comprehensive biological characteristics. Radiomics, by extracting a large number of medical imaging features and combining machine learning (ML) and statistical analysis methods, can identify and quantify disease characteristics, offering new perspectives for the prediction, evaluation, and treatment of TN. This article summarized the latest research progress in radiomics for the qualitative diagnosis of TN, focusing on the application of radiomics methods based on ultrasound, CT, and MRI in TN. Additionally, it discussed the challenges faced by radiomics in TN diagnosis and treatment, emphasizing its importance in improving clinical decision-making, in order to provide references for personalized and precise management of TN. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application of blood flow analysis method based on computational fluid dynamics and 4D Flow MRI in diagnosis and treatment of cardiovascular and cerebrovascular diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.028</link>
<description><![CDATA[In recent years, blood flow analysis of cardiovascular and cerebrovascular diseases has played an increasingly important role in clinic. Computational fluid dynamics (CFD) and 4D flow magnetic resonance imaging (4D Flow MRI) both can realize the visualization and quantification of blood flow in cardiovascular and cerebrovascular diseases. CFD is the calculation of blood flow by solving the hydrodynamic governing equations based on medical images. It has high spatial and temporal resolution, but depends on model setting and vessel wall boundary condition assumptions. 4D Flow MRI can directly measure true blood flow in the body, but the acquisition time is long and the resolution and accuracy are limited. Therefore, this paper aims to review the advantages and limitations of CFD and 4D Flow MRI, the combined application of the two methods, and the application progress in cardiovascular and cerebrovascular diseases, in order to provide clinicians with a beneficial tool for the diagnosis and treatment of vascular diseases. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress of cardiac magnetic resonance in the assessment of left ventricular remodeling after myocardial infarction]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.029</link>
<description><![CDATA[Adverse left ventricular remodeling (ALVR) after myocardial infarction (MI) is a pathological change in myocardial structure or function, which has a significant impact on the prognosis of patients. Heart failure (HF) after ALVR is the main cause of increased morbidity and mortality in myocardial infarction patients worldwide. At present, it has been confirmed that a variety of factors lead to the occurrence of ALVR after MI, among which inflammation is one of the important factors. Cardiac magnetic resonance (CMR) can provide information about the structure, function, perfusion, and tissue characteristics. It can provide important information related to patient prognosis through imaging evaluation and guide early monitoring and treatment of people at high risk of ALVR. In addition, as CMRs continue to evolve, multiple derived CMRs and their combination with artificial intelligence can predict clinical endpoints in prospective trials and evaluate the efficacy of certain drugs. This article reviews the pathophysiology of ALVR after MI, and explains how CMR can guide the treatment of clinical patients through its imaging markers and help clinical selection of new treatments. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application and research progress of MRI radiomics in brain metastases from lung cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.030</link>
<description><![CDATA[Brain metastases (BMs) are the most prevalent intracranial malignancies, with lung cancer BMs being particularly common in clinical practice, closely associated with the poor prognosis and high mortality of lung cancer. Therefore, precise diagnosis and treatment of lung cancer BMs are of paramount importance for their clinical management. Magnetic resonance imaging (MRI) has been widely regarded as the imaging gold standard for the diagnosis and prognosis assessment of BMs due to its high sensitivity and specificity. MRI radiomics enables a more detailed characterization of the internal structure and heterogeneity of tumors through high-throughput feature extraction methods. The quantitative imaging features extracted from MRI are closely related to the biological behavior and clinical prognosis of tumors, providing clinicians with richer decision-support information to enhance the accuracy of diagnosis and personalization of treatment. Recent studies have shown that MRI radiomics demonstrates great potential in improving the accuracy and efficiency of clinicians in diagnosing, classifying, treating, and predicting the prognosis of lung cancer BMs. This article aims to comprehensively summarize the latest applications of MRI radiomics in lung cancer BMs in terms of data segmentation processing and model establishment, in order to provide insights for research in this emerging field. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on artificial intelligence in MRI for breast cancer diagnosis and treatment response prediction]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.031</link>
<description><![CDATA[Breast cancer seriously endangers the life and health of women. The key to improve the survival rate and quality of life of the breast cancer patients are accurate and efficient diagnoses and treatment strategies. In recent years, the research of artificial intelligence (AI) based on breast MRI has made remarkable progress in early diagnosis, accurate treatment and prognosis evaluation. This review summarizes the research progress of AI MRI in differentiation of benign and malignant breast lesions, breast cancer molecular classification, quantitative evaluation of breast background parenchyma enhancement, prediction of axillary lymph node status, prognosis and recurrence prediction in recent years. Simultaneously, the current limitations and challenges are presented to provide a reference for optimizing diagnostic and treatment strategies and promoting the development of AI technology based on breast MRI. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in radiomics and deep learning in predicting colorectal cancer-related gene mutations]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.032</link>
<description><![CDATA[Colorectal cancer is a prevalent malignant tumor of the digestive tract, characterized by a high mortality rate. In recent years, precision treatment models for colorectal cancer based on molecular markers have emerged as significant advancements in disease management. In this context, rat sarcoma (RAS) and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) genes serve as critical indicators for the molecular subtyping of colorectal cancer, playing an essential role in developing treatment strategies, assessing tumor prognosis, and predicting recurrence risk. Currently, pathological biopsy remains the gold standard for diagnosing genetic mutations in colorectal cancer patients; however, its invasive nature and limited reproducibility hinder its application in clinical decision-making processes. Given this situation, there is an urgent need to develop non-invasive and precise methods for detecting genetic mutations in colorectal cancer patients to provide more effective support for clinical decisions. This article aims to review the advancements in imaging genomics and deep learning concerning predicting gene mutations associated with colorectal cancer, offering new research perspectives and potential therapeutic strategies for the clinical diagnosis and management of these patients. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The research progress of MRI in predicting the efficacy of neoadjuvant chemoradiotherapy for rectal cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.033</link>
<description><![CDATA[Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME) has become a globally recognized treatment strategy for locally advanced rectal cancer (LARC). Postoperative pathological examination is the gold standard for evaluating the efficacy of nCRT, but it is invasive and has a certain lag, and cannot be routinely used for preoperative clinical diagnosis. As a non-invasive method for evaluating the efficacy of nCRT, imaging can achieve early and dynamic assessment of the efficacy of nCRT in LARC patients. Among them, MRI is the preferred imaging examination for evaluating the efficacy of nCRT in LARC patients. Therefore, using MRI-related techniques to non-invasively predict the efficacy of nCRT in LARC patients before surgery has important clinical value and can help provide individualized treatment plans for patients and avoid overtreatment. This article aims to systematically review the research progress of conventional MRI, functional MRI, MRI radiomics, and deep learning and other MRI imaging techniques in evaluating the efficacy of nCRT in LARC patients, and to prospect the future development trends. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of synthetic magnetic resonance imaging in prostate cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.034</link>
<description><![CDATA[Synthetic MRI (SyMRI) is a new type of rapid quantitative MRI technique, which can obtain multiple quantitative maps and contrast-weighted images in a short scanning time, and can non-invasively obtain objective quantitative parameters of tissues and provide more information about tissue composition from a microscopic perspective. The longitudinal relaxation time T1, transverse relaxation time T2 and proton density (PD) obtained by Synthetic MRI (SyMRI) play an important role in the differential diagnosis, prediction of aggressiveness and prognosis of prostate cancer. This paper describes the basic principles of SyMRI technology and reviews the existing literature on the application of integrated MRI technology in prostate cancer, aiming to improve the early diagnosis of prostate cancer and provide more additional information for prostate cancer treatment. In addition, this paper discusses the future development direction of this technology based on the current application of prostate cancer, hoping to provide a reference for subsequent research. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application of metal-based theranostic magnetic resonance imaging contrast agents in tumor imaging and therapy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.035</link>
<description><![CDATA[Magnetic resonance imaging (MRI), with its excellent spatial resolution and soft tissue contrast, plays a key role in the diagnosis, treatment, and prognosis evaluation of tumors. MR contrast agents enhance the sensitivity of lesion detection by shortening relaxation times, thereby improving the contrast between lesions and surrounding normal tissues. In recent years, the development of novel theranostic MRI contrast agents has become a research hotspot. Among them, metal-based MRI contrast agents have attracted particular attention due to their unique physicochemical properties, which not only significantly enhance the efficacy of tumor therapy but also provide diverse surface modification strategies. In this review, we systematically summarize the recent advances in metal-based MRI contrast agents in the fields of tumor imaging and therapy. We elaborate on their imaging and therapeutic mechanisms, as well as their applications in the emerging field of "theranostics." Finally, we briefly discuss the major technical bottlenecks and key challenges that need to be addressed in the integration of tumor diagnosis and therapy using metal-based MRI contrast agents. Through a comprehensive review of the application of metal-based MRI contrast agents in integrated diagnosis and therapy for tumors, this review provides theoretical support for the further development of this field and offers valuable insights for future research exploration. With the continuous advancement of nanotechnology, materials science, and biomedicine, metal-based MRI contrast agents are expected to play an even greater role in enhancing tumor diagnostic capabilities and achieving more precise therapeutic effects in the future. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance habitat imaging in the prognosis of malignant tumors]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.036</link>
<description><![CDATA[Traditional radiology has made great progress in evaluating the prognosis of malignant tumors by analyzing the quantitative information in medical images and finding and quantifying the subtle features that are difficult to be recognized by naked eyes. However, there are still some challenges in radiology, which generally treat tumors as a relatively evenly distributed whole internally and cannot fully express tumor heterogeneity. Tumor heterogeneity is the main cause of tumor progression, treatment resistance, and recurrence. By segmenting images, the tumor habitat map can be generated, which can reflect the heterogeneity of tumor tissues, molecules, and their microenvironment. This provides a new perspective for understanding the biological characteristics and therapeutic response of tumors and helps to evaluate the prognosis of malignant tumors. For example, it has been found that in glioblastoma (GBM), pre- and post-treatment volume changes in hyper-vascular cellular habitat and hypo-vascular cellular habitat correlate strongly with tumor progression, providing potential imaging markers for predicting patient survival after surgery. This article reviews the latest research progress of magnetic resonance habitat imaging in the prognosis of malignant tumors. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of quantitative vessel wall imaging with magnetic resonance parameters in carotid atherosclerosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2025.02.037</link>
<description><![CDATA[Carotid atherosclerosis is a key pathogenic factor for ischemic stroke, and accurate identification of vulnerable plaques is essential for optimizing diagnosis and treatment strategies. Quantitative vessel wall imaging with magnetic resonance parameters can noninvasively assess plaque composition and microstructure, quantify plaque vulnerability, and provide objective evidence for stroke risk prediction and individualized treatment, which has become a research hotspot in precision medicine. This article reviews the technical progress and clinical application of quantitative vessel wall imaging with magnetic resonance parameters in carotid atherosclerosis, analyzes the limitations of existing research and future development directions, and is expected to provide reliable quantitative imaging markers for clinical use in vulnerable plaque identification, risk stratification and efficacy monitoring. ]]></description>
<pubDate>Thu,20 Feb 2025 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
